ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

DCT Will Consider Planning, Center Core Supplemental, Program Project Grants In $5 Million Surgical Oncology Development Effort

October 10, 1980

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

September 30, 2011

NCI Director Says Gallo’s Work On HIV Should Have Been Recognized.

October 10, 2008